Vanda Ruling Offers New Guide To Generic Labeling Disputes
The U.S. Court of Appeals for the District of Columbia Circuit's Aug. 18 decision in Vanda Pharmaceuticals v. U.S. Food and Drug Administration presents an unusual Hatch-Waxman Act result: Vanda won...To view the full article, register now.
Already a subscriber? Click here to view full article